ConductScience.org, home

Paper17869367

Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.

Malugin A and 2 others. J Control Release, 2007. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells. Papers, record 17869367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17869367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.
PubMed
Journal
J Control Release
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2025-05-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Malugin AA
2Kopecková PP
3Kopecek JJ

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcrylamidesMajor topic
Antibiotics, AntineoplasticMajor topic
Cell CycleMajor topic
Cell NucleusMajor topic
DNA FragmentationMajor topic
DoxorubicinMajor topic
Ovarian NeoplasmsMajor topic
Apoptosis
Biological Availability
Cell Line, Tumor
Cell Survival
Female
Humans
Microscopy, Confocal
Microscopy, Fluorescence
Molecular Structure

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA051578NCI NIH HHSUnited StatesR01CA051578PubMed and NIH
CA51578NCI NIH HHSUnited StatesR01CA051578PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111018556Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells.J Control Release2000https://conductscience.org/library/papers/11018556PubMed
211289131Cell surface-directed interaction of anthracyclines leads to cytotoxicity and nuclear factor kappaB activation but not apoptosis signaling.Cancer Res2001https://conductscience.org/library/papers/11289131PubMed
311295216Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells.J Control Release2001https://conductscience.org/library/papers/11295216PubMed
411943391Differences in the intracellular fate of free and polymer-bound doxorubicin.J Control Release2002https://conductscience.org/library/papers/11943391PubMed
515380639HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitro.J Control Release2004https://conductscience.org/library/papers/15380639PubMed
6593972Soluble biomedical polymers.Polim Med1977https://conductscience.org/library/papers/593972PubMed
717402705The same drug but a different mechanism of action: comparison of free doxorubicin with two different N-(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugates in EL-4 cancer cell line.Bioconjug Chem2007https://conductscience.org/library/papers/17402705PubMed
89741911Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.J Control Release1998https://conductscience.org/library/papers/9741911PubMed
98866655HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro.J Drug Target1996https://conductscience.org/library/papers/8866655PubMed
1015981920HPMA copolymer-bound doxorubicin induces apoptosis in human ovarian carcinoma cells by a Fas-independent pathway.Mol Pharm2004https://conductscience.org/library/papers/15981920PubMed
1116036307Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.J Drug Target2005https://conductscience.org/library/papers/16036307PubMed
1216247491Classification of cell death: recommendations of the Nomenclature Committee on Cell Death.Cell Death Differ2005https://conductscience.org/library/papers/16247491PubMed
1316269198Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity.J Control Release2005https://conductscience.org/library/papers/16269198PubMed
1416749867HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function.Mol Pharm2006https://conductscience.org/library/papers/16749867PubMed
1516900224Polymer conjugates as anticancer nanomedicines.Nat Rev Cancer2006https://conductscience.org/library/papers/16900224PubMed
1617092838
Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and use to study the intracellular fate of HPMA copolymer - doxorubicin.
J Drug Target2006https://conductscience.org/library/papers/17092838PubMed
1717092839
HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition.
J Drug Target2006https://conductscience.org/library/papers/17092839PubMed
1817129632Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells.J Control Release2007https://conductscience.org/library/papers/17129632PubMed
1910728603Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma.Int J Cancer2000https://conductscience.org/library/papers/10728603PubMed
2010699287Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.J Control Release2000https://conductscience.org/library/papers/10699287PubMed

See all 23 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
42927187Spatiotemporal control of protein degradation: Advances in stimuli-responsive nano-PROTACs for precision cancer therapy.Asian J Pharm Sci2026https://conductscience.org/library/papers/42927187PubMed
40141443Gemcitabine-Doxorubicin Combination Polymer-Drug Conjugate Prepared by SPAAC Click Chemistry: In Vitro Characterization.Int J Mol Sci2025https://conductscience.org/library/papers/40141443PubMed
39913003Pharmacogenomics influence on MDR1-associated cancer resistance and innovative drug delivery approaches: advancing precision oncology.Med Oncol2025https://conductscience.org/library/papers/39913003PubMed
38734315Hydrophilic biomaterials: From crosslinked and self-assembled hydrogels to polymer-drug conjugates and drug-free macromolecular therapeutics.J Control Release2024https://conductscience.org/library/papers/38734315PubMed
37765185Innovative Design of Targeted Nanoparticles: Polymer-Drug Conjugates for Enhanced Cancer Therapy.Pharmaceutics2023https://conductscience.org/library/papers/37765185PubMed
35629120Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines.J Pers Med2022https://conductscience.org/library/papers/35629120PubMed
34359599Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors.Cancers (Basel)2021https://conductscience.org/library/papers/34359599PubMed
33396604Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33396604PubMed
32962018Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs.Molecules2020https://conductscience.org/library/papers/32962018PubMed
30174339Advanced architectures in the design of responsive polymers for cancer nanomedicine.J Appl Polym Sci2018https://conductscience.org/library/papers/30174339PubMed
28098511Hemodynamic effects of HPMA copolymer based doxorubicin conjugate: A randomized controlled and comparative spectral study in conscious rats.Nanotoxicology2017https://conductscience.org/library/papers/28098511PubMed
28031879Photodynamic therapy and imaging based on tumor-targeted nanoprobe, polymer-conjugated zinc protoporphyrin.Future Sci OA2015https://conductscience.org/library/papers/28031879PubMed
25529761Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.Cancer Sci2015https://conductscience.org/library/papers/25529761PubMed
24892741Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates.J Drug Target2014https://conductscience.org/library/papers/24892741PubMed
22707853Polymeric conjugates for drug delivery.Chem Mater2012https://conductscience.org/library/papers/22707853PubMed
22400063Protease-activated drug development.Theranostics2012https://conductscience.org/library/papers/22400063PubMed
22278817Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.Macromol Biosci2012https://conductscience.org/library/papers/22278817PubMed
21452893Targeted albumin-based nanoparticles for delivery of amphipathic drugs.Bioconjug Chem2011https://conductscience.org/library/papers/21452893PubMed
20845065HPMA copolymer-aminohexylgeldanamycin conjugates targeting cell surface expressed GRP78 in prostate cancer.Pharm Res2010https://conductscience.org/library/papers/20845065PubMed
19919846HPMA copolymers: origins, early developments, present, and future.Adv Drug Deliv Rev2010https://conductscience.org/library/papers/19919846PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17869367

GET https://conductscience.org/api/papers/v1/17869367/references?page=2